SynchroSep-MS: Parallel LC Separations for Multiplexed Proteomics
Journal of the American Society for Mass Spectrometry · 2025
DOI: 10.1021/jasms.5c00207 ↗At a glance
Journal article in Journal of the American Society for Mass Spectrometry, 2025. Written by Noah M Lancaster and 10 co-authors. Institution: Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States. Major MEDLINE topics: Proteomics, Mass Spectrometry, Proteome. Cited 2 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, NHLBI NIH HHS, National Institute of General Medical Sciences.
Abstract (original language)
Achieving high throughput remains a challenge in MS-based proteomics for large-scale applications. We introduce SynchroSep-MS, a novel method for parallelized, label-free proteome analysis that leverages the rapid acquisition speed of modern mass spectrometers. This approach employs multiple liquid chromatography columns, each with an independent sample, simultaneously introduced into a single mass spectrometer inlet. A precisely controlled retention time offset between sample injections creates distinct elution profiles, facilitating unambiguous analyte assignment. We modified the DIA-NN workflow to effectively process these unique parallelized data, accounting for retention time offsets. Using a dual-column setup with mouse brain peptides, SynchroSep-MS detected approximately 16,700 unique protein groups, nearly doubling the peptide information obtained from a conventional single proteome analysis. The method demonstrated excellent precision and reproducibility (median protein %RSDs less than 4%) and high quantitative linearity (median R2 greater than 0.96) with minimal matrix interference. SynchroSep-MS represents a new paradigm for data collection and the first example of label-free multiplexed proteome analysis via parallel LC separations, offering a direct strategy to accelerate throughput for demanding applications such as large-scale clinical cohorts and single-cell analyses without compromising peak capacity or causing ionization suppression.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
- Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
- Morgridge Institute for Research, Madison, Wisconsin 53715, United States.
- Quantitative Proteomics Laboratory, Charité - Universitätsmedizin Berlin, Berlin 10117, Germany.
- Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, United States.
- Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan 48109, United States.
ORCID profiles: Noah M Lancaster, Daniel A Polasky, Alexey I Nesvizhskii, Katherine A Overmyer, Scott T Quarmby, Joshua J Coon
Funding
- NIGMS NIH HHS
- NHLBI NIH HHS
- National Institute of General Medical Sciences
Cite
APA
Lancaster, N. M., Chen, L. Y., Zhao, B., Anderson, B. J., Probasco, M. D., Demichev, V., Polasky, D. A., Nesvizhskii, A. I., Overmyer, K. A., Quarmby, S. T., & Coon, J. J. (2025). SynchroSep-MS: Parallel LC Separations for Multiplexed Proteomics. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.5c00207
Vancouver
Lancaster NM, Chen LY, Zhao B, Anderson BJ, Probasco MD, Demichev V, et al. SynchroSep-MS: Parallel LC Separations for Multiplexed Proteomics. Journal of the American Society for Mass Spectrometry. 2025. doi:10.1021/jasms.5c00207
BibTeX
@article{Lancaster2025,
author = {Lancaster, Noah M and Chen, Li-Yu and Zhao, Bingnan and Anderson, Benton J and Probasco, Mitchell D and Demichev, Vadim and Polasky, Daniel A and Nesvizhskii, Alexey I and Overmyer, Katherine A and Quarmby, Scott T and Coon, Joshua J},
title = {SynchroSep-MS: Parallel LC Separations for Multiplexed Proteomics},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2025},
doi = {10.1021/jasms.5c00207}
}
EUVIMED